A month after Kaleo came under fire for raising the price of its opioid antidote 600 percent to $4,100, the Virginia drugmaker announced it will launch a generic version at a fraction of the cost, according to a STAT news…
Pharmacy
Gilead Sciences has named Daniel O'Day — a longtime Roche Holdings executive — as its new CEO, according to The Wall Street Journal.
What began as a lawsuit over the prices of two drugs has grown to become a 47-state case involving at least 16 generic drug companies and 300 drugs, according to The Boston Globe.
Actelion Pharmaceuticals, a drug company based in South San Francisco, Calif., reached a $360 million settlement with the the Department of Justice to resolve accusations that it violated the False Claims Act.
Amazon has hired Jason Tzau, PharmD, to help oversee the company's employee benefits plan, according to the Puget Sound Business Journal.
Walgreens is teaming up with FedEx to launch a nationwide next-day delivery service for prescription drugs.
A bipartisan drug pricing bill — introduced by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore. — looks to crack down on "big pharma's games," according to The Hill.
Despite opposition by several parties, Takeda Pharmaceutical shareholders voted to approve its multibillion dollar deal to buy Shire, valued at about $58 billion, according to The Wall Street Journal.
CVS Health, the drugstore chain that operates one of the largest pharmacy benefit managers in the nation, will launch a new "guaranteed net cost" pricing model that will pass its health plan clients 100 percent of any rebates, discounts or…
Pharma giant AbbVie donated $50 million to Memphis, Tenn.-based St. Jude Children's Research Hospital, the largest single donation in the hospital's history.